Form 4: ResMed Inc. Executive Michael J. Rider Reports Stock Sale
SEC Form 4
Global General Counsel Michael J. Rider sold 882 shares of ResMed Inc. stock on August 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 20, 2024, Michael J. Rider, the Global General Counsel of ResMed Inc., sold 882 shares of ResMed Common Stock at a price of $231 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 11, 2024.
- Following the transaction, Rider directly owns 10,512 shares of ResMed Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged trading plan, suggesting it's not necessarily indicative of the executive's outlook on the company.
Industry Context
Insider trading activity is always closely watched by investors as it can provide signals, though often not definitive, about a company's prospects. Rule 10b5-1 plans are designed to allow insiders to trade without accusations of acting on non-public information.
Key Dates
| Date | Description |
|---|---|
| May 11, 2024 | Date of adoption of the Rule 10b5-1 plan |
| August 20, 2024 | Date of stock sale transaction |
| August 21, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.